Health ❯ Public Health ❯ Obesity

Weight Management

GLP-1 Drugs Medications Pharmaceuticals Weight-loss Drugs Weight Loss Drugs Clinical Implications Weight Loss Treatments Healthcare Services Prehabilitation BMI Measurement NHS Services Mounjaro Mindfulness Weight Loss Injections Treatment Strategies Medication Access Cravings Semaglutide Medication Use GLP-1 Medications NHS Policies Prescription Medications Drug Accessibility Personalized Medicine Weight-Loss Injections Anti-Obesity Medications Dietary Drugs Impact on Industries Pharmaceutical Interventions Medications for Obesity Lifestyle Intervention Injection Therapies Weight Loss Medications Dietary Support

Global Analysis Shows Obesity Slowing in Wealthy Nations and Accelerating Elsewhere

A new measure of year‑to‑year change flags record 2024 increases in many countries.

Roche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase 2 as Phase 3 Nears

Trump Cites 'Very Fat' Friend's Ozempic Story to Decry Price Gap

Lilly’s Daily Obesity Pill Sustains Weight Loss After Switch From Wegovy or Zepbound

U.S. Obesity Rate Drops to 37% as GLP-1 Use Surges, Gallup Finds